338 related articles for article (PubMed ID: 16980297)
1. Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.
Watson IR; Blanch A; Lin DC; Ohh M; Irwin MS
J Biol Chem; 2006 Nov; 281(45):34096-103. PubMed ID: 16980297
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
3. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
4. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cooperation of MDM2 and E2F1 contributes to TAp73 transcriptional activity.
Kasim V; Huang C; Zhang J; Jia H; Wang Y; Yang L; Miyagishi M; Wu S
Biochem Biophys Res Commun; 2014 Jul; 449(3):319-26. PubMed ID: 24845566
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p73 activity by post-translational modifications.
Conforti F; Sayan AE; Sreekumar R; Sayan BS
Cell Death Dis; 2012 Mar; 3(3):e285. PubMed ID: 22419114
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
8. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
[TBL] [Abstract][Full Text] [Related]
9. Transactivation-dependent and -independent regulation of p73 stability.
Dulloo I; Sabapathy K
J Biol Chem; 2005 Aug; 280(31):28203-14. PubMed ID: 15919663
[TBL] [Abstract][Full Text] [Related]
10. p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.
Soond SM; Barry SP; Melino G; Knight RA; Latchman DS; Stephanou A
Cell Cycle; 2008 May; 7(9):1214-23. PubMed ID: 18418051
[TBL] [Abstract][Full Text] [Related]
11. Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2.
Sayan BS; Yang AL; Conforti F; Tucci P; Piro MC; Browne GJ; Agostini M; Bernardini S; Knight RA; Mak TW; Melino G
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12877-82. PubMed ID: 20615966
[TBL] [Abstract][Full Text] [Related]
12. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells.
Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A
Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of diverse p53 isoforms on TAp73 transcriptional activity and apoptosis.
Zorić A; Horvat A; Slade N
Carcinogenesis; 2013 Mar; 34(3):522-9. PubMed ID: 23188674
[TBL] [Abstract][Full Text] [Related]
14. TAp73 promotes anabolism.
Amelio I; Antonov AA; Catani MV; Massoud R; Bernassola F; Knight RA; Melino G; Rufini A
Oncotarget; 2014 Dec; 5(24):12820-934. PubMed ID: 25514460
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the p73 protein stability and degradation.
Oberst A; Rossi M; Salomoni P; Pandolfi PP; Oren M; Melino G; Bernassola F
Biochem Biophys Res Commun; 2005 Jun; 331(3):707-12. PubMed ID: 15865926
[TBL] [Abstract][Full Text] [Related]
16. p73 induces apoptosis by different mechanisms.
Ramadan S; Terrinoni A; Catani MV; Sayan AE; Knight RA; Mueller M; Krammer PH; Melino G; Candi E
Biochem Biophys Res Commun; 2005 Jun; 331(3):713-7. PubMed ID: 15865927
[TBL] [Abstract][Full Text] [Related]
17. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
[TBL] [Abstract][Full Text] [Related]
18. Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line.
Goldschneider D; Blanc E; Raguénez G; Barrois M; Legrand A; Le Roux G; Haddada H; Bénard J; Douc-Rasy S
J Cell Sci; 2004 Jan; 117(Pt 2):293-301. PubMed ID: 14676279
[TBL] [Abstract][Full Text] [Related]
19. P53 and p73 differ in their ability to inhibit glucocorticoid receptor (GR) transcriptional activity.
Zhang L; Nie L; Maki CG
Mol Cancer; 2006 Dec; 5():68. PubMed ID: 17150106
[TBL] [Abstract][Full Text] [Related]
20. Interplay between TAp73 Protein and Selected Activator Protein-1 (AP-1) Family Members Promotes AP-1 Target Gene Activation and Cellular Growth.
Subramanian D; Bunjobpol W; Sabapathy K
J Biol Chem; 2015 Jul; 290(30):18636-49. PubMed ID: 26018080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
